785 articles
A new non-dopaminergic drug for Parkinson's OFF episodes enters final trial phase with 341 patients and $20M in fresh funding.
A newly discovered CRISPR tool called Cas12a2 selectively destroys cancer cells by detecting their unique RNA signals, cutting tumor volume by 50% in mice.
A new Nature Communications study shows self-collected fingerprick blood tests reliably flag Alzheimer's biomarkers, enabling earlier risk detection.
Adults with stronger circadian rest-activity patterns show measurable signs of slower biological aging in blood-based biomarkers.
UC Davis scientists created novel brain-healing molecules that activate key serotonin receptors tied to neuroplasticity — without triggering hallucinations.
Optimism bias tricks people into believing their diet is better than average — even when the evidence says otherwise.
A major meta-analysis reveals widespread underdiagnosis of Lewy body dementia, the second most common degenerative dementia after Alzheimer's.
PCOS is being renamed polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its complex, multi-system nature and reduce diagnostic delays.
A Chinese RCT finds endovascular thrombectomy meaningfully improves functional independence in medium-vessel stroke patients with moderate-to-severe deficits.
Telitacicept slashed urinary protein by 59% in 39 weeks, signaling a major advance for a kidney disease affecting millions worldwide.
Two patients developed rare choroidal eye disease on dulaglutide; vision fully recovered after stopping the GLP-1 drug.
The FDA fast-tracked sonrotoclax for relapsed mantle cell lymphoma, with 52% of patients responding in trials — a new option when others fail.
